Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages - News-Medical.Net

8/12/2022 12:00:00 AM2 years 8 months ago

In a new study, researchers developed bispecific-antibodies (bsAbs) against SARS-CoV-2 Omicron sub-lineages.

In a recent study posted to the bioRxiv* preprint server, researchers developed bispecific-antibodies (bsAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sub-lineages… [+5228 chars]

full article...